Insight Molecular Diagnostics Inc. (IMDX) EBITDA Margin (2020 - 2026)
Insight Molecular Diagnostics (IMDX) recorded EBITDA Margin of -4492.47% in Q2 2026, down 2700.38 percentage points from -1792.08% a year earlier but up 7326.28 percentage points from the prior quarter.
Insight Molecular Diagnostics Inc. (IMDX) EBITDA Margin (2020 - 2026) Analysis & Trends
On a TTM basis, Insight Molecular Diagnostics' EBITDA Margin came in at -2864.97% as of Jun 30, 2026, down 1414.77 percentage points year-over-year; for FY2025, it came in at -1206.34%, up 1950.97 percentage points from FY2024.
- Annual EBITDA Margin has a five-year change of +1204.60 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at -3157.31% in FY2024 (-1597.23 pp), -1560.08% in FY2023 (-223.44 pp), -1336.64% in FY2022 (+918.32 pp) and -2254.96% in FY2021 (+155.98 pp).
- Quarterly EBITDA Margin has ranged from -11818.75% in Q1 2026 to 2128.62% in Q1 2023 over the past five years.
- On a year-over-year basis, EBITDA Margin rose in five of the last eight quarters, with an average year-over-year change of -832.35 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 7431.91 percentage points in Q3 2025, against a drop of 11524.04 percentage points in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at -11818.75% (Q1 2026), -2007.20% (Q4 2025) and -4024.62% (Q3 2025).
Peer Comparison
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4,492.47% |
| Mar 31, 2026 | -11,818.75% |
| Dec 31, 2025 | -2,007.20% |
| Sep 30, 2025 | -4,024.62% |
| Jun 30, 2025 | -1,792.08% |
| Mar 31, 2025 | -294.71% |
| Dec 31, 2024 | -2,219.11% |
| Sep 30, 2024 | -11,456.52% |
| Jun 30, 2024 | -4,140.38% |
| Mar 31, 2024 | -5,075.00% |
| Dec 31, 2023 | -5,050.00% |
| Sep 30, 2023 | -1,418.88% |
| Jun 30, 2023 | -1,692.66% |
| Mar 31, 2023 | 2,128.62% |
| Dec 31, 2022 | -3,816.06% |
| Sep 30, 2022 | -505.97% |
| Jun 30, 2022 | -112.24% |
| Mar 31, 2022 | -474.21% |
| Dec 31, 2021 | -960.49% |
| Sep 30, 2021 | -1,256.00% |
Insight Molecular Diagnostics Inc. EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "IMDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();